+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hyperthyroidism"

From
From
From
Global Endocrine Testing Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Global Endocrine Testing Market - Forecasts from 2022 to 2027

  • Report
  • March 2022
  • 124 Pages
  • Global
From
Epidemiology of Thyroid Disorders - Product Thumbnail Image

Epidemiology of Thyroid Disorders

  • Book
  • January 2020
Endocrine Secrets. Edition No. 7 - Product Thumbnail Image

Endocrine Secrets. Edition No. 7

  • Book
  • September 2019
  • 10 Results (Page 1 of 1)
Loading Indicator

Hyperthyroidism is a condition in which the thyroid gland produces an excessive amount of thyroid hormones. It is a common endocrine disorder that affects people of all ages, genders, and ethnicities. Symptoms of hyperthyroidism can include weight loss, increased appetite, rapid heart rate, anxiety, irritability, and fatigue. Treatment options for hyperthyroidism include antithyroid medications, radioactive iodine, and surgery. The hyperthyroidism market is a subset of the larger endocrinology market. It is a growing market, driven by increasing prevalence of the condition, technological advancements, and the availability of new treatments. The market is expected to grow at a steady rate over the next few years. Some companies in the hyperthyroidism market include AbbVie, Inc., AstraZeneca, GlaxoSmithKline, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Sanofi, and Takeda Pharmaceutical Company Limited. Show Less Read more